A5102990078- Ocular Diseases and Behçet’s Syndrome
- Retinal and Optic Conditions
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Retinal and Macular Surgery
- Autoimmune and Inflammatory Disorders
- Inflammatory Bowel Disease
- Syphilis Diagnosis and Treatment
- Streptococcal Infections and Treatments
- Hemoglobinopathies and Related Disorders
- Herpesvirus Infections and Treatments
- Intraoperative Neuromonitoring and Anesthetic Effects
- Sarcoidosis and Beryllium Toxicity Research
- Retinal Imaging and Analysis
- IgG4-Related and Inflammatory Diseases
- Retinoids in leukemia and cellular processes
- Allergic Rhinitis and Sensitization
- Intraocular Surgery and Lenses
- Drug-Induced Ocular Toxicity
- Cerebral Venous Sinus Thrombosis
- Retinal Development and Disorders
- Long-Term Effects of COVID-19
- Iron Metabolism and Disorders
- Vasculitis and related conditions
- Blood groups and transfusion
Elman Retina Group
2020-2025
MedStar Georgetown University Hospital
2022-2024
Georgetown University
2022-2024
Washington Hospital
2022-2024
Palo Alto Institute
2024
MedStar Health
2022
Southern California Eye Institute
2019-2020
University of Southern California
2019-2020
Rutgers, The State University of New Jersey
2012
Atopic dermatitis (AD) is a chronic inflammatory skin disease mediated by the helper T cell type 2 cytokines interleukin 4 (IL-4) and/or IL-13.1 Dupilumab monoclonal antibody that inhibits signaling of IL-4 and IL-13 via receptor blockade.2 treatment results in significant improvement AD signs symptoms health-related quality life patients with moderate to severe AD.3
Purpose: To identify the temporal relationship and clinical characteristics of epiretinal membrane (ERM) macular edema (ME) formation in uveitic eyes.Methods: A total 269 subjects (444 eyes) met study inclusion criteria. Comprehensive ophthalmic examination, spectral domain-optical coherence tomography (SD-OCT), testing were carried out.Results: Of 444 eyes, 229 eyes (51.6%) developed an ERM, whereas 87 (19.1%) ME. The odds ratios (ORs) systemic disease causing uveitis resulting ERM ME...
Biologics have proven to be essential therapeutic agents in immune-mediated systemic diseases. Ophthalmologic adverse effects been reported the use of more traditional agents, such as TNF-α inhibitors, but there are limited data on ocular side associated with newer generation biologics.In this report, we present a case suspected ustekinumab-associated recurrent sclerouveitis.To best our knowledge, is first type seen ustekinumab injections. Our goal add existing literature order better...
To explore the incidence of adverse events after bilateral same-day intravitreal 0.7-mg dexamethasone implant (SDIDI) injections.We performed an IRB approved, single-center, retrospective review patients receiving SDIDI injections from January 1, 2016 to October 31, 2021 and reviewed that occurred within 3 months injection.A total 206 (412 eyes) were in 59 patients. Ocular hypertension or addition intraocular pressure (IOP) lowering drops 121 (29.4%) eyes IDI. Two (0.5%) required glaucoma...
Purpose Patients with Crohn's disease (CD) and subsequent ocular manifestations may have worse outcomes when compared to matched patients CD without disease.
Purpose: To evaluate the use of selective vs. non-selective cyclo-oxygenase inhibitors (COXIs) for treatment chronic non-infectious, non-necrotizing scleritis and episcleritis.
To report a case of bilateral posterior placoid-like maculopathy and macular hole associated with vitamin A deficiency.A 72-year-old male presented nyctalopia progressive vision loss in both eyes. Examination multimodal imaging were consistent bilaterally the right eye. workup for infectious, inflammatory, paraneoplastic etiologies revealed severely low serum level. Two months after initiation repletion, there was improvement best-corrected Snellen visual acuity as well closure. diagnosis...